NCT05424913View on ClinicalTrials.gov

Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

August 16, 2023

Study Completion Date

August 16, 2023

Conditions
LipodystrophyDunnigan Syndrome
Interventions
OTHER

research-specific blood sample

blood sample of 50 ml maximum levels of serum Insulin Regulated Amino Peptidase, lipidome markers and inflammation markers

Trial Locations (1)

97448

CHU de la Réunion, Saint-Pierre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT05424913 - Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy | Biotech Hunter | Biotech Hunter